Bring next-generation
therapies to underserved patients
We consistently bring leading innovative therapies to underserved patients
Diversified pipeline
We have built world-competitive pipeline targeting innovative biological therapies in the autoimmune and oncology therapeutic areas
Autoimmune and
chronic diseases
chronic diseases
Oncology
30+
In R&D
10+
In Clinical Trials
5
Bispecific Antibody
2
ADC
Efficient in-house R&D capability and
fully-integrated R&D platfrom
Meet the cGMP standards of NMPA, FDA, and EMA
Powered by efficient fully integrated in-house R&D capabilities, Keymed has established an industry-leading innovation engine to accelerate the development of novel treatments.